Sheila: A 58-year-old African American woman diagnosed with rheumatoid arthritis with inadequate response to methotrexate
Rheumatology
Curriculum:
Rheumatoid Arthritis: Improving Treatment Decisions and Quality of Care in Clinical Practice
Rheumatoid Arthritis: Improving Treatment Decisions and Quality of Care in Clinical Practice
Credits:
1 ANCC Contact Hours 1 AMA PRA Category 1 Credit(s) ™
1 ANCC Contact Hours 1 AMA PRA Category 1 Credit(s) ™
Launch Date:
March 09, 2016
March 09, 2016
Expiration Date:
The accreditation for this activity has expired.
The accreditation for this activity has expired.
Primary Audience:
Rheumatologists and other healthcare professionals, such as primary care physicians, internists, physician assistants, nurse practitioners, advanced practice nurses, and nurses who care for patients with RA
Relevant Terms:
Rheumatoid Arthritis, Shared decision-making
Stanley Cohen, MD
Stanley Cohen, MD
Clinical Professor, Department of Internal Medicine
University of Texas Southwestern Medical School
Co-Director, Division of Rheumatology
Presbyterian Hospital
Dallas, TX
Bio
Stanley Cohen, MD
Clinical Professor, Department of Internal Medicine
University of Texas Southwestern Medical School
Co-Director, Division of Rheumatology
Presbyterian Hospital
Dallas, TX
Clinical Professor, Department of Internal Medicine
University of Texas Southwestern Medical School
Co-Director, Division of Rheumatology
Presbyterian Hospital
Dallas, TX
Elizabeth Kirchner, MSN
Elizabeth Kirchner, MSN
Department of Rheumatic and Immunologic Diseases
Cleveland Clinic
Cleveland, Ohio
Bio
Elizabeth Kirchner, MSN
Department of Rheumatic and Immunologic Diseases
Cleveland Clinic
Cleveland, Ohio
Department of Rheumatic and Immunologic Diseases
Cleveland Clinic
Cleveland, Ohio
| 1. | Describe updates from the European League Against Rheumatism (EULAR) and American College of Rheumatology (ACR) guidelines and apply appropriate new recommendations into clinical practice | 2. | Employ the "treat-to-target" approach to rheumatoid arthritis (RA) management via incorporation of routine use of validated composite disease-activity measures, biomarkers, and instruments |
| 3. | Compare and contrast efficacy, safety, and tolerability of available biologic agents used in the presence of disease- and patient-related variables such as, comorbidities, risk tolerance, and dosing convenience | 4. | Utilize effective communication and education to engage RA patients in shared decision-making on treatment choices |
| 1. | Describe updates from the European League Against Rheumatism (EULAR) and American College of Rheumatology (ACR) guidelines and apply appropriate new recommendations into clinical practice |
| 2. | Employ the "treat-to-target" approach to rheumatoid arthritis (RA) management via incorporation of routine use of validated composite disease-activity measures, biomarkers, and instruments |
| 3. | Compare and contrast efficacy, safety, and tolerability of available biologic agents used in the presence of disease- and patient-related variables such as, comorbidities, risk tolerance, and dosing convenience |
| 4. | Utilize effective communication and education to engage RA patients in shared decision-making on treatment choices |
Faculty Disclosures
In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias. The following faculty have indicated that they may have a relationship, which in the context of their presentation(s), could be perceived as a potential conflict of interest
Program Faculty
Stanley Cohen, MD
Clinical Professor, Department of Internal Medicine
University of Texas Southwestern Medical School
Co-Director, Division of Rheumatology
Presbyterian Hospital
Dallas, TXPresbyterian Hospital
Dr. Cohen has indicated that he has no relationships that, in the context of his presentation, could be perceived as a potential conflict of interest.
| Abbvie Pharmaceuticals | Membership on advisory committee or review panels Other activities from which remuneration is received or expected: investigator |
Elizabeth Kirchner, MSN
Department of Rheumatic and Immunologic Diseases
Cleveland Clinic
Cleveland, Ohio
Ms. Kirchner has indicated that she has no relationships that could be perceived as a potential conflict of interest.
ACTIVITY DIRECTOR
Leonard Calabrese, DO
Professor of Medicine
Cleveland Clinic, Lerner College of Medicine
Case Western Reserve University
R.J. Fasenmeyer Chair, Clinical Immunology
Orthopaedic and Rheumatologic Institute
Cleveland, Ohio
Dr. Calabrese has indicated that he has a relationship, which in the context of his presentation, could be perceived as a potential conflict of interest:
| Abbvie Pharmaceuticals | Consulting Teaching and Speaking |
| BMS | Consulting Teaching and Speaking |
| Crescendo | Teaching and Speaking |
| GSK | Consulting |
| Genentech/Roche | Consulting Teaching and Speaking |
| Janssen | Consulting Teaching and Speaking |
| Pfizer | Consulting |
| Sanofi Aventis | Consulting |
| UCB | Consulting |
Accreditor Disclosure
The Cleveland Clinic Center for Continuing Education staff involved in the planning and content review of this activity have indicated they have no relationships that could be perceived as a potential conflict of interest.
Publishing Staff Disclosures
Haymarket Medical Education staff involved in the planning and content review of this activity have indicated they have no relationships that could be perceived as a potential conflict of interest.
Accreditation Statement(s)
The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Cleveland Clinic Enterprise is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
Credit Designation Statement(s)
The Cleveland Clinic Foundation Center for Continuing Education designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity is awarded 1.00 hours of CE credit.
Disclaimer
The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition. The viewpoints expressed in this CME/CE activity are those of the authors/faculty. They do not represent an endorsement by Cleveland Clinic or Haymarket Medical Education. In no event will Cleveland Clinic or Haymarket Medical Education be liable for any decision made or action taken in reliance upon the information provided through this CME/CE activity.
If you have any questions relating to the accreditation of this activity, please contact Cleveland Clinic at 216-444-9990.
Method of Participation Instructions
To obtain credit, a score of 70% or better on the post-test is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/Exam History, which you can access at any time.
Privacy Policy
HME Privacy Policy will be added automatically to each activity.
COURSE VIEWING REQUIREMENTS
| Supported Browsers: Internet Explorer 9.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 Google Chrome 28.0+ for Windows, Mac OS, or Linux Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux Safari 6.0+ for Mac OSX 10.7 and above |
© 2007-2024 HealthCourse, Inc. All rights reserved.
